Hugel KRX:145020KOSDAQ
휴젤 · Korean news coverage and regulatory filings, organized.
Articles, 24h1
Articles, 7 days2
DART filings, 7 days2
Articles tracked2since Sep 11
In Q2 2026, Hugel reported revenue of ₩138bn, up 25.1% year on year, and operating profit of ₩56.0bn. Hugel (휴젤) appeared in 2 Korean news articles and 2 DART filings over the past seven days. Coverage peaked on Sep 14 with 2 articles. It was most often mentioned alongside Medy-Tox and Daewoong.
Hugel quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩138bn | +25.1% | ₩56.0bn | ₩44.7bn |
| Q1 2026 | ₩117bn | +29.9% | ₩47.6bn | ₩40.6bn |
| Q4 2025 derived | ₩119bn | +21.3% | ₩57.8bn | ₩39.8bn |
| Q3 2025 | ₩106bn | +0.8% | ₩47.4bn | ₩38.0bn |
| Q2 2025 | ₩110bn | +15.5% | ₩56.7bn | ₩38.2bn |
| Q1 2025 | ₩89.8bn | +20.9% | ₩39.0bn | ₩30.9bn |
| Q4 2024 derived | ₩98.2bn | +10.4% | ₩46.5bn | ₩41.4bn |
| Q3 2024 | ₩105bn | +23.9% | ₩53.4bn | ₩42.0bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Hugel top stories 2 weeks, by number of outlets
- 1
- 2
